Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography

Similar documents
and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Paul C. Taylor, M.D. ORIGINAL ARTICLES

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery*

Coronary Atherosclerosis in Valvular Heart Disease

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis

Ventricular Function and the Native Coronary Circulation Five Years after Myocardial Revascularhation

The Healing Characteristics of Autogenous Saphenous Vein Used in the Reconstruction of Previouslv Implanted Arterial Saphenous Vein Grafts

Coronary atherosclerotic heart disease remains the number

Relation of Saphenous Vein Graft Obstruction to Serum Cholesterol Levels

Quantification of Coronary Arterial Narrowing at Necropsy in Acute Transmural Myocardial Infarction

Further Evaluation. Technique of Coronary Artery Bypass. of the Circular Sequential Vein Graft

Angiographic 5-Year Follow-up Study of Right Gastroepiploic Artery Grafts

Results of Reoperation

Analysis of Mortality Within the First Six Months After Coronary Reoperation

S surgical procedures. A major cause of perioperative

TSDA ACGME Milestones

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Changing profile of patients undergoing redo-coronary artery surgery q

Pulmonary Valve Replacement

Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report

Coronary artery bypass grafting (CABG) is a temporary treatment for a

Sex dilferences in early and long-term results of

Right Coronary Artery With Anomalous Origin and Slit Ostium

Importance of the third arterial graft in multiple arterial grafting strategies

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

R standard procedure, accounting for 4% to 6% of all. Bilateral Internal Mammary Artery Grafts in Reoperative and Primary Coronary Bypass Surgery

Received 20 January 2008; received in revised form 30 June 2008; accepted 11 July 2008; Available online 23 August 2008

Distribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience.

I internal mammary artery (IMA) is widely accepted as

Angioplasty in Total Coronary Artery Occlusion

Improved long-term survival has been demonstrated by

can flow in the smaller artery (fig. 1). In the present

Distal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty

Surgery for Acquired Cardiovascular Disease

ery: Comparison of Predicted and Observed Resu ts

(Ann Thorac Surg 2008;85:845 53)

Surgical Therapy for Prinzmetal's Variant Angina

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Serum triglycerides and HDL cholesterol major predictors of long-term survival after coronary surgery

Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies

The clinical and prognostic benefits of coronary artery bypass grafting (CABG)

The use of both the left and right internal thoracic arteries (ITAs) for revascularization

Coronary Artery Stenosis Following Aortic Valve Replacement and Intermittent Intracoronary Cardioplegia

Mandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Setting The setting was a hospital. The economic study was carried out in Australia.

Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization

Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses

Management of Fusiform Ascending Aortic Aneurysms

Left main stem coronary artery disease

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Saphenous Vein Autograft Replacement

Reoperation for Coronary Atherosclerosis

The operative mortality rate after redo valvular operations

Adult Cardiac Surgery

Postoperative Symptomatic Internal Thoracic Artery Stenosis and Successful Treatment With PTCA

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes

T the ST segment during attacks caused by coronary

Comparison of Early and Late Mortality in Men and Women After Isolated Coronary Artery Bypass Graft Surgery in Stockholm, Sweden, 1980 to 1989

Coronary arteriographic study of mild angina

Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization

ORIGINAL ARTICLES. Great progress has been made in the last decade to make saphenous vein bypass grafting one of the safest major

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine

Surgery for Coronary Artery Disease. Arterial Versus Venous Bypass Grafts in Patients With In-Stent Restenosis

Are We Making Progress With Percutaneous Saphenous Vein Graft Treatment? A Comparison of 1990 to 1994 and 1995 to 1998 Results

2017 Cardiology Survival Guide

Coronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates

Coexistence of symptomatic coronary artery disease

F rent techniques of hypothermic cardioplegic arrest

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients

Incidence of coronary artery disease in patients

Ischemic mitral regurgitation (IMR) is an insufficiency of

Enhanced CABG is in Your Hands

Myocardial Bridge: Surgical Outcome and Mid-term Follow up

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Disease of the aortic valve is frequently associated with

The history of coronary artery surgery has taken place

Improved Noninvasive Assessment of Coronary Artery Bypass Grafts With 64-Slice Computed Tomographic Angiography in an Unselected Patient Population

Direct Coronary Surgery Utilizing Multiple-Vein Bypass Grafts

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.

Operative Risk in Patients with Previous Coronary Artery Bypass

Long-term patency of as well as patient survival associated

1 Functions of endothelial cells include all the following EXCEPT. 2 Response to vascular injury is characterised by

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Outpatient Cardiac Rehabilitation

Coronary artery bypass grafting (CABG) increases life

The Radial Artery Versus the Saphenous Vein Graft in Contemporary CABG: A Case-Matched Study

Anatomic variants of the normal coronary artery circulation

Safe Approach for Redo Coronary Artery Bypass Grafting Preventing Injury to the Patent Graft to the Left Anterior Descending Artery

Ischemic Mitral Regurgitation

Coronary Artery Bypass Grafting Using the Gastroepiploic Artery in 1,000 Patients

Coronary angiography in patients undergoing carotid artery stenting reveals

Impact of donor-transmitted coronary atherosclerosis on quality of life (QOL) and quality-adjusted life years (QALY) after heart transplantation

Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement

Common Codes for ICD-10

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

IN SITU RIGHT INTERNAL THORACIC ARTERY GRAFT VIA TRANSVERSE SINUS FOR REVASCULARIZATION OF POSTEROLATERAL WALL: EARLY RESULTS IN 116 CASES

T attention as an alternative and durable graft in coronary

Patencies of 2,127 Arterial to Coronary Conduits Over 15 Years

Transcription:

Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper management of saphenous vein grafts showing minimal angiographic evidence of atherosclerosis at the time of reoperation for progressive atherosclerosis in the native coronary circulation or for severe atherosclerosis in other saphenous vein grafts is uncertain. Following the occlusion of vein grafts in 2 patients and 12 years after operation but only 2 years after arteriography demonstrated no major abnormalities in the grafts, we adopted a policy of elective replacement of all saphenous vein grafts, irrespective of angiographic findings, when reoperation was necessary 5 or more years after the initial operation. etween July, 194, and May, 195,16 patients had repeat coronary artery bypass grafting 6 to 13 years (mean, 9 years) after the initial procedure. Complete revascularization was carried out in all patients. In each, it included replacement of at least 1 saphenous vein graft showing no severe obstruction (less than 30% of the luminal diameter) and no (5 patients), minimal (S), or moderate (3) luminal irregularities by angiography. y pathological examination, 3 of the grafts had minimal, 5 had moderate, and had severe atherosclerotic changes present. These changes were generally more diffuse than those observed by angiography. ecause angiography underestimates the severity of the atherosclerotic degeneration in saphenous vein grafts and because of the propensity of the atherosclerotic disease to progress at an unpredictable rate, we recommend routine replacement of all saphenous vein grafts at the time of reoperation if done 5 or more years after the initial procedure. Long-term follow-up studies of patients having coronary artery bypass grafting (CG) with autologous saphenous vein have shown that degenerative changes indistinguishable from atherosclerosis develop in a substantial number of these grafts [l-41. During repeat CG procedures for recurrent symptoms resulting from progression of the atherosclerotic process in the native coronary circulation or in the previously inserted vein grafts, From the Division of Cardiothoracic Surgery and the Department of Pathology, Washington University School of Medicine, St. Louis, MO. Presented at the Thirty-second nnual Meeting of the Southern Thoracic Surgical ssociation, oca Raton, FL, Nov -9, 195. ddress reprint requests to Dr. Marshall, Division of Cardiovascular and Thoracic Surgery, Jewish Hospital of St. Louis, 216 S Kingshighway lvd, St. Louis, MO 631. those grafts that are occluded or severely diseased are replaced. The proper management of vein grafts showing no or minimal angiographic evidence of atherosclerosis is not established. Following the occlusion of single vein grafts in 2 patients and 12 years postoperatively but only 2 years after angiography demonstrated no severe atherosclerotic disease in these grafts, we adopted a policy of elective replacement of all vein grafts in patients undergoing repeat CG 5 or more years following the initial procedure (Fig 1). In this report, we present the angiographic and pathological findings in vein grafts electively replaced at reoperation in 16 patients and a plan of management for similar patients that is based on these findings. Material and Methods etween July, 194, and ugust, 195, 16 patients with at least 1 previously inserted saphenous vein graft showing luminal irregularities of less than 30% of the luminal diameter by angiography, underwent repeat CG. The mean age of these patients was 63 years (range, 3 to 9 years), and (63%) were men. The mean length of time the saphenous vein grafts in question had been in place was 9 years (range, 6 to 13 years). The mean number of grafts placed at the previous operation was 2.3 (range, 1 to 3). Recurrent angina pectoris was the indication for reoperation in 15 patients, and failure of an aortic porcine bioprosthesis was the indication in 1 patient with coexistent coronary artery disease. Coronary arteriography was performed in all patients prior to repeat CG. The vein grafts showing less than 30% obstruction of the luminal diameter in at least two projections were classified as follows: -No areas of luminal irregularity -Luminal irregularities with no areas of obstruction greater than 15% of the diameter of the graft -Luminal irregularities greater than 15% but less than 30% of the diameter of the graft Four patients had a single graft at the initial operation and underwent repeat CG because of progression of disease in the native circulation. ll 4 of these grafts were classified as normal angiographically. Three patients had 2 grafts placed initially. One had recurrence of angina due to progression of disease in the native coronary circulation with both grafts classified as normal by angiography. The other 2 patients had occlusion of 1 163 nn Thorac Surg 42:163-16, ug 196

164 The nnals of Thoracic Surgery Vol 42 No 2 ugust 196 Fig I. () rteriogram shows suphenous vein graft with minimal luminal irregularity 5 years after insertion. () rteriogram made 2 yeurs later demonstrates occlusion of same vein graft. graft, minimal disease in the other graft, and progression of disease in the native circulation. The remaining 9 patients received 3 grafts initially. Four of these patients had occlusion of 1 graft and severe disease in a second graft. Three of these 4 patients had a third graft with minimal disease present, and the fourth patient had moderate disease present in the graft electively replaced. Two of the 9 patients had severe disease in 2 grafts with minimal disease in the third graft in 1 patient and moderate disease in the third graft in the other. In 2 patients, 2 grafts were occluded with minimal disease in the third graft in 1 patient and moderate disease in the third graft in the other. One patient had occlusion of 1 graft with minimal disease in the other 2 grafts. Seven of these 9 patients also had severe progression of disease in the native coronary arteries. In the 2 patients who had 2 grafts with luminal irregularities of less than 30%, the least diseased graft was evaluated. Fourteen of the patients had elective CG, and 2 had urgent operation for severe unstable angina. Thirteen of the operations were secondary procedures, and 3 were tertiary. One patient had concomitant replacement of a malfunctioning aortic bioprosthesis, and 1 had mitral valve replacement for coexistent mitral regurgitation. ll repeat operations were performed with hypothermic (26" to 30"C), nonpulsatile cardiopulmonary bypass with moderate hemodilution. cold (4 C) oxygenated hyperkalemic crystalloid cardioplegic solution was used for myocardial protection. Reversed saphenous vein grafts (single or sequential) were used in all patients, and the left internal mammary artery was used in patients. The mean number of arteries grafted was 3.6 (range, 2 to 5). Segments of the 16 grafts electively replaced and containing the areas of luminal irregularity when present, were opened longitudinally and visually inspected for evidence of atherosclerosis. Thirteen of the grafts were photographed, and using tracings of these photographs, the fraction of the total intimal surface involved with atherosclerosis was determined by planimetry. The vein grafts were classified according to the extent of involvement of the intimal surface: minimal, less than 15%; moderate, 16 to 30%; and severe, more than 30%. Photographs were not available for 3 of the grafts, and the severity of the atherosclerosis in these grafts was estimated from gross and histological examination. Results There was 1 hospital death (6%). The patient could not be weaned from cardiopulmonary bypass at the end of the procedure. Postmortem examination of the heart showed multiple old myocardial infarctions and acute hemorrhagic infarction in the posterior left ventricular wall in the distribution of an occluded saphenous vein graft. One patient (6%) sustained a perioperative myocardial infarction, which probably resulted from inadequate flow through a new left internal mammary artery graft to the left anterior descending coronary artery. The angiographic and pathological findings in the 16 patients are shown in Table 1. None of the 5 grafts with a normal angiographic appearance were free from atherosclerosis (Fig 2). The angiographic estimate of the severity of atherosclerosis underestimated the severity determined by pathological examination in 13 (1%) of the 16 grafts (Table 2). The underestimation was substantial in 9 (56%): with normal angiographic findings, there were moderate or severe pathological changes; with minimal angiographic changes, there were severe pathological changes (Figs 3, 4). There was no correlation between the length of time the grafts had been in place and the severity of the atherosclerotic involvement (Table 3). Comment Long-term follow-up studies of patients having CG with autologous saphenous vein have shown that degenerative changes indistinguishable from atherosclerosis develop in a substantial number of these grafts [l-31. mong grafts evaluated angiographically to 12

Fig 2. () rteriogram shows no luminal irregularities in the saphenous vein graft (normal). () The same vein graft after excision reveals minimal atherosclerotic changes. Fig 3. () rteriogram shows luminal irregularities of less than 15% of the luminal diameter (minimal disease). () The same vein graft after excision demonstrates severe atherosclerotic changes. Fig 4. () rteriogram reveals luminal irregularities of greater than 15% but less than 30% of the luminal diameter (moderate disease). () The Same vein graft after excision shows moderate atherosclerotic changes. 165

166 The nnals of Thoracic Surgery Vol 42 No 2 ugust 196 Table 1. Summary of Patient Data Patient ge Of Severity of therosclerosis % Of No., ge Graft Graft (Yr) (yr) ngiographic Pathological Surface 1. 5 2. 5 3. 62 4. 62 5. 4 6.. 52. 3 9. 59. 63 11. 60 12. 60 13. 9 14. 46 15. 16. 0 6 6 9 11 12 12 13 " " " 13 54 N 1 36 N 3 26 3 N 39 5 "Photograph was not available; severity was estimated from gross and histological examination. N = not available. Table 2. Comparison of ngiographic and Pathological Findings Pathological ngiographic Total 0 2 2 1 5 0 1 1 6 0 0 2 1 3 Total 0 3 5 16 Table 3. Comparison of ge of Graft and Severity of therosclerotic Changes ge of Graft (yr) therosclerotic Change 6-9-11 12-13 Total 2 0 1 3 3 2 0 5 3 3 2 Total 5 3 16 years after operation by Campeau and co-workers [l], 42 (39%) were occluded. Of the 66 patent grafts, 40 were considered unsatisfactory primarily because of late changes attributed to atherosclerosis. Only 26 grafts (24%) were classified as satisfactory (unchanged or with diffuse narrowing of less than 20% of the luminal diameter). Campeau and associates [2] also found that in grafts patent 6 to 1 months postoperatively, 30% had occluded at to 12 years and 32% had developed new atherosclerotic changes, defined as wall irregularities and focal narrowings by angiography. They also showed that the incidence of changes increased from 16% in the interval between 1 year and 5 to years postoperatively to 36% in the interval between 5 to years and to 12 years. Lytle and colleagues [3] discovered that among a group of 501 patients studied a mean of 15 months postoperatively who had normal grafts by angiography and who were restudied at a mean of months postoperatively, new stenoses or irregularities had developed in 1% of the grafts and 26% were occluded. These studies indicate that atherosclerotic changes occur with time and are progressive, although the rate of progression in an individual patient or graft cannot be accurately predicted. The study of Campeau and colleagues [2] also suggested that the rates of progression of atherosclerosis and occlusion of the grafts are substantially increased between the sixth and twelfth years compared with the first 5 years. Smith and Geer [5] in autopsy studies found that atherosclerotic changes were present only in saphenous vein grafts that had been in place more than 39 months, and that 0% of the vein grafts examined had such changes. Kern and colleagues [6] also reported major atherosclerotic changes in surgically excised saphenous vein grafts that had been in place an average of 6 to years in 13 of 40 patients. ll of the vein grafts in the present study had been in place more than 6 years, and all had atherosclerotic changes. The cases of the 2 patients seen initially and that prompted this analysis demonstrate that the rate of progression of disease, even in grafts judged to be normal or minimally diseased by angiography, can be rapid. These grafts, which were inserted to 12 years previously, progressed to total occlusion in 2 years. Underestimation by angiographic criteria of the pathological changes in the native coronary circulation has been previously demonstrated []. In our study, there was substantial underestimation by angiography of the atherosclerotic disease in the saphenous vein grafts in 56% of the grafts examined. Previous studies [4, 1 demonstrated that reoperative CG can be performed without excessive risk. There was only 1 death and 1 major complication (perioperative myocardial infarction) in this series. The decision to replace mildly diseased grafts required the insertion of 1 additional graft in 14 patients and 2 grafts in 2 patients. The extra ten to twenty minutes of myocardial ischemia and the twenty to forty minutes of total operating time were tolerated without difficulty in all surviving patients and were not associated with increased morbidity. ecause of the underestimation of the atherosclerotic

16 Marshall, Saffitz, Kouchoukos: Management of Saphenous Vein Grafts at Reoperation disease in saphenous vein grafts by angiography, the frequency with which atherosclerotic disease exists in such grafts after 5 years, the inability to predict the rate of progression of the atherosclerosis in a given graft or patient, and the safety with which reoperative CG can be performed, we believe that saphenous vein grafts that have been in place more than 5 years should be replaced regardless of their angiographic appearance. ddendum Since submission of this manuscript for publication, 2 additional patients have had replacement of vein grafts with normal angiographic appearance as previously defined. One had moderate atherosclerotic changes involving 1% of the luminal surface, and 1 had severe atherosclerotic changes involving 39% of the luminal surface. oth grafts had been in place years. The technical assistance of Therese Wedige-Stecher is gratefully acknowledged. References 1. Campeau L, ourassa MG, Enjalbert M, Lesperance J: Fate of saphenous vein aortocoronary bypass grafts -12 years after surgery. In Rapaport E (ed): Cardiology Update: Review for Physicians. msterdam, Elsevier, 194, pp 143-15 2. Campeau L, Enjalbert M, Lesperance J, et al: therosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5- years, and -12 years after surgery. Circulation 6:Suppl2:1, 193 3. Lytle W, Loop FD, Cosgrove DM, et al: Long-term (5-12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 9:24, 195 4. Loop FD, Cosgrove DM, Kramer JR, et al: Late clinical and arteriographic results in 500 coronary arterial reoperations. J Thorac Cardiovasc Surg 1:65, 191 5. Smith SH, Geer JC: Morphology of saphenous veincoronary artery bypass grafts. rch Pathol Lab Med 13, 193 6. Kern WH, Wells WJ, Meyer W The pathology of surgically excised aortocoronary saphenous vein bypass grafts. m J Surg Pathol5:491, 191. rnett EN, Isner JM, Redwood DR, et al: Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. nn Intern Med 91:350, 199. Schaff HV, Orzulak T, Gersh J, et al: The morbidity and mortality of reoperation for coronary artery disease and analysis of late results with use of actuarial estimate of event-free interval. J Thorac Cardiovasc Surg 5:50, 193